Indicators of Inflammation and Coagulation in Sepsis

NCT01128283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2014-09-12

No results posted yet for this study

Summary

We will collect blood samples from patients with the diagnosis of sepsis and other ICU patients. We will describe the course of different mediator levels and organ injury markers and follow their progression throughout the course of the study.

Conditions

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Gary T. Kinasewitz, MD · University of Oklahoma

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01128283 on ClinicalTrials.gov